1 |
Zhou, Q. and Liao, J. K. : Pleiotropic effects of statins. Basic research and clinical perspectives. Circ. J. 74, 818 (2010).
DOI
ScienceOn
|
2 |
Hatzigeorgiou, C. and Jackson, J. L. : Hydroxymethylglutarylcoenzyme A reductase inhibitors and osteoporosis: a metaanalysis. Osteoporos. Int. 16, 990 (2005).
DOI
|
3 |
Szczepanska-Szerej, A., Kurzepa, J., Wojczal, J. and Stelmasiak, Z. : Simvastatin-induced prevention of the increase in TNFlevel in the acute phase of ischemic stroke. Pharmacol. Rep. 59, 94 (2007).
|
4 |
Saito, A., Saito, N., Mol, W., Furukawa, H., Tsutsumida, A., Oyama, A., Sekido, M., Sasaki, S. and Yamamoto, Y. : Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells. Melanoma Res. 18, 85 (2008).
DOI
ScienceOn
|
5 |
Glynn, S. A., O'Sullivan, D., Eustace, A. J., Clynes, M. and O'Donovan, N. : The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells. BMC Cancer 8, 9 (2008).
DOI
ScienceOn
|
6 |
Lee, Y. S. : Lovastatin induces apoptotic cell death by activation of intracellular signal in HepG2 human hepatoma cells. J. Appl. Pharmacol. 15, 137 (2007).
DOI
ScienceOn
|
7 |
Schallreuter, K. U., Hasse, S., Rokos, H., Chavan, B., Shalbaf, M., Spencer, J. D. and Wood, J. M. : Cholesterol regulates melanogenesis in human epidermal melanocytes and melanoma cells. Exp. Dermatol. 18, 680 (2009).
DOI
ScienceOn
|
8 |
Galus, R., Niderla, J., Sladowski, D., Sajjad, E., Wlodarski, K. and Jozwiak, J. : Fluvastatin increases tyrosinase synthesis induced by a-melanocyte-stimulating hormone in B16F10 melanoma cells. Pharmacol. Rep. 62, 164 (2010).
DOI
|
9 |
Copaja, M., Venegas, D., Aranguiz, P., Canales, J., Vivar, R., Avalos, Y., Garcia, L., Chiong, M., Olmedo, I., Catalan, M., Leyton, L., Lavandero, S. and Diaz-Araya, G. : Simvastatin disrupts cytoskeleton and decreases cardiac fibroblast adhesion, migration and viability. Toxicology 294, 42 (2012).
DOI
ScienceOn
|
10 |
Yoshioka, S., Terashita, T., Yoshizumi, H. and Shirasaka, N. : Inhibitory effects of whisky polyphenols on melanogenesis in mouse B16 melanoma cells. Biosci. Biotechnol. Biochem. 75, 2278 (2011).
DOI
ScienceOn
|
11 |
Huang, Y. C., Liu, K. C. and Chiou, Y. L. : Melanogenesis of murine melanoma cells induced by hesperetin, a Citrus hydrolysate-derived flavonoid. Food Chem. Toxicol. 50, 653 (2012).
DOI
ScienceOn
|
12 |
Busca, R. and Ballotti, R. : Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res. 13, 60 (2000).
DOI
ScienceOn
|
13 |
Bentley, N. J., Eisen, T. and Goding, C.R. : Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator. Mol. Cell. Biol. 14, 7996 (1994).
DOI
|
14 |
Liang, C. H., Chou, T. H., Tseng, Y. P. and Ding, H. Y. : trans- Caffeic acid stearyl ester from Paeonia suffruticosa inhibits melanin synthesis by cAMP-mediating down-regulation of - melanocyte-stimulating hormone-stimulated melanogenesis signaling pathway in B16 cells. Biol. Pharm. Bull. 35, 2198 (2012).
DOI
|
15 |
deOliveira, A. R., Castrucci, A. M., Visconti, M. A. : Cellular signalling in vertebrate pigment cells. Braz. J. Med. Biol. Res. 29, 1743 (1996).
|
16 |
Carsberg, C. J., Jones, K. T., Sharpe, G. R. and Friedmann, P. S. : Intracellular calcium modulates the responses of human melanocytes to melanogenic stimuli. J. Dermatol. Sci. 9, 157 (1995).
DOI
ScienceOn
|
17 |
Parker, C. and Sherbet, G. V. : The channel blocker verapamil enhances melanogenesis without altering metastatic potential in the B16 murine melanoma. Melanoma Res. 3, 347 (1993).
DOI
|
18 |
Jin, S. H., Lee, Y. Y. and Kang, H. Y. : Methyl--cyclodextrin, a specific cholesterol-binding agent, inhibits melanogenesis in human melanocytes through activation of ERK. Arch. Dermatol. Res. 300, 451 (2008).
DOI
|
19 |
Schallreuter, K. U., Kothari, S., Chavan, B. and Spencer, J. D. : Regulation of melanogenesis-controversies and new concepts. Exp. Dermatol. 17, 395 (2008).
DOI
ScienceOn
|
20 |
Chang, T. S. : An updated review of tyrosinase inhibitors. Int. J. Mol. Sci. 10, 2440 (2009).
DOI
ScienceOn
|
21 |
Sposito, A. C. and Chapman, M. J. : Statin therapy in acute coronary syndromes: mechanistic insight into clinical benefit. Arterioscler. Thromb. Vasc. Biol. 22, 1524 (2002).
DOI
ScienceOn
|
22 |
Muck, A. O., Seeger, H. and Wallwiener, D. : Inhibitory effect of statins on the proliferation of human breast cancer cells. Int. J. Clin. Pharmacol. Ther. 42, 695 (2004).
DOI
|
23 |
Boissy, R. E. : Melanosome transfer to and translocation in the keratinocyte. Exp. Dermatol. 12 Suppl 2, 5 (2003).
DOI
ScienceOn
|
24 |
Gillbro, J. M. and Olsson, M. J. : The melanogenesis and mechanisms of skin-lightening agents-existing and new approaches. Int. J. Cosmet. Sci. 33, 210 (2011).
DOI
ScienceOn
|